Medical Research Related News
Discover how immunotherapy for cancer could be better than aggressive chemotherapy
At diagnosis, people with recurrent head and neck cancer are currently given an aggressive chemotherapy, however immunotherapy for cancer may be the better option.
According...
An advancement of genome analysis could detect diseases more quickly
Diseases caused by genetic changes could be detected more readily thanks to an advance in DNA genome analysis software.
The development of the genome analysis...
Could quantum sensors lead to a new generation of MRI scanners?
Researchers have detected magnetic fields with extreme sensitivity by combining machine learning with quantum sensors – Meaning a new wave of MRI scanners may...
Jellyfish antidote: Is CRISPR genome editing the solution?
Using CRISPR genome editing, researchers at the University of Sydney, Australia, may have discovered a jellyfish antidote for the most venomous creature on earth.
The...
EIT Health paving the way for healthcare leaders of the future
Discover the launch of EIT Health’s prestigious 2019 Summer School Programme, targeting the healthcare leaders of the future.
This week, EIT Health opens registrations for...
What do you know about the new CRISPR Cas9 gene editing system?
Reported in Genome Medicine, a new CRISPR Cas9 gene editing system has been developed which adds genes to create mouse models of liver cancer.
A...
Did you know that face-to-face HIV testing methods are preferred?
Published in Plos Medicine, a new study find that face-to-face HIV testing is the preferred option by men who have sex with men.
The research...
The role of new technologies in creating a patient-centric future
Christian Hebenstreit, of Medidata Solutions, talks how becoming patient-centric in clinical trials means being open to new ways of working.
Clinical trials have historically been...
Delving into the medical cannabis industry with the Annual Medcann World Forum
This November 2019 Malta is set to host the 2nd Annual Medcann World Forum, providing an inspiring perspective of the latest advances from the...
The Innovative Medicines Initiative, mitochondrial dysfunction and Parkinson’s
€7 million awarded for Parkinson’s research through Innovative Medicines Initiative - it’s time we took a look at mitochondrial dysfunction and its link with...
Colonoscopy failures: detecting colorectal cancer across Europe may be affected
Colonoscopy failures are hindering the chances of detecting colorectal cancer across Europe which, claiming 175,000 deaths per year, is the continent’s second largest cancer...
Revolutionising blockchain technology in healthcare
Bringing global leaders together to discuss blockchain technology in healthcare, discover the international summit taking place in Dubai.
More than 14,000 attendees join international summit...
Time to increase the understanding of influenza vaccine effectiveness
There has been a call for researchers to join new efforts to study brand-specific influenza vaccine effectiveness.
A call has been issued for research institutes...
Explore the world of hereditary autoimmune diseases
According to researchers from Karolinska Institute, Sweden, different types of hereditary autoimmune diseases are related, some more than others.
Researchers using the world's largest twin...
The world of medical cannabis: the importance of patient experience
In the dynamically evolving world of medical cannabis, the topic of policy, cultivation, distribution and efficacy has been exhausted, but what about the actual...
Aducanumab trials for Alzheimer’s disease stopped early
Pharmaceutical companies Biogen and Eisai announced they are to discontinue two phase III Aducanumab trials of the Alzheimer’s drug.
The ENGAGE and EMERGE trials were...
The Innovative Medicines Initiative: tackling neurodegenerative diseases
The Innovative Medicines Initiative launches a public-private coordination and support action to develop an operational platform for its projects battling neurodegenerative diseases.
Madrid, Spain, 21...
Adrenomed’s Adrecizumab: the septic shock study that’s passed analysis
Adrenomed’s septic shock study introduces Adrecizumab, a first-in-class antibody targeting Adrenomedullin, to restore and maintain vascular integrity in early septic shock.
Hennigsdorf, Germany, 21 March...
Curing HIV: are we a step closer to tackling the disease?
Could carriers of HIV become infection free? Discover how Professor Ravi Gupta of University College London and the University of Cambridge, UK, presented a...
Cancer screening device: detecting cancer from breath
Detecting cancer from breath doesn’t sound possible right? Well, SniffPhone is the new cancer screening device that enables early diagnosis of gastric cancer by...
